Public Profile

Sinclair Pharma Limited

Sinclair Pharma Limited, a prominent player in the global aesthetics and dermatology industry, is headquartered in Great Britain. Founded in 1971, the company has established itself as a leader in innovative medical solutions, focusing on advanced products for skin health and aesthetic enhancement. With a strong presence in Europe, Asia, and the Americas, Sinclair Pharma is renowned for its unique offerings, including injectable fillers and skin rejuvenation treatments. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted name in the market. Sinclair Pharma's core products, such as the well-regarded Ellansé and Silhouette Soft, are distinguished by their long-lasting results and biocompatibility. With a reputation for quality and innovation, Sinclair Pharma continues to make strides in the aesthetic sector, contributing to the evolving landscape of cosmetic medicine.

DitchCarbon Score

How does Sinclair Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Sinclair Pharma Limited's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Sinclair Pharma Limited's reported carbon emissions

Sinclair Pharma Limited, headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments in detail. However, the company may be engaged in various sustainability initiatives typical of the pharmaceutical industry, which often includes efforts to reduce environmental impact and improve energy efficiency. As the industry increasingly focuses on climate action, Sinclair Pharma Limited may align with broader trends towards sustainability, although specific commitments or targets have not been disclosed.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sinclair Pharma Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sinclair Pharma Limited is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sinclair Pharma Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

B. Braun Se

DE
Chemicals nec
Updated 2 days ago

Genesis Biosystems, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Stryker

US
Health and social work services (85)
Updated 2 days ago

Galderma S.A.

CH
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

CollPlant

IL
Other business services (74)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers